Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted HealthcarePRESCRIPTION DRUGS ARE THE THIRD LEADING CAUSE OF DEATH AFTER HEART DISEASE AND CANCER. In his latest ground-breaking book, Peter C Gotzsche exposes the pharmaceutical industries and their charade of fraudulent behaviour, both in research and marketing where the morally repugnant disregard for human lives is the norm. He convincingly draws close co |
Contents
Organised crime the business model of big pharma | |
Very few patients benefit from the drugs they take | |
Clinical trials a broken social contract with patients | |
What do thousands of doctors on industry payroll | |
Hard sell | |
Impotent drug regulation | |
Fraudulent celecoxib trial and other lies | |
Blood glucose was fine but the patients died | |
Psychiatry the drug industrys paradise | |
Pushing children into suicide with happy pills | |
Intimidation threats and violence to protect sales | |
Busting the industry myths | |
General system failure calls for a revolution | |
Having the last laugh at big pharma | |
Other editions - View all
Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare Peter Gotzsche No preview available - 2017 |
Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare Peter C. Gøtzsche,Drummond Rennie No preview available - 2013 |
Common terms and phrases
academic adverse analysis antidepressant antipsychotics approved asked AstraZeneca Available online benefit benzodiazepines big pharma Bristol-Myers Squibb cancer cardiovascular caused celecoxib clinical trials Cochrane Database Syst committee company's compared conflicts of interest corruption crimes Danish Database Syst Rev deaths depression diabetes disease disorder doctors documents dose drug drug agencies drug companies drug industry drug regulator editor Engl England Journal escitalopram ethical fluoxetine fraud Glaxo GlaxoSmithKline Gøtzsche PC harms healthcare Healy heart attacks increased inhibitors internal investigators JAMA Journal of Medicine Lancet Lenzer Lundbeck marketing medical journals Merck meta-analysis million naproxen NSAIDs off-label organisations outcomes paper paroxetine patients Pfizer Pharmaceutical Industry physicians pills pioglitazone placebo prescribe problem protocols Prozac psychiatrists published randomised trials risk Roche rofecoxib rosiglitazone safety scientific misconduct scientists showed side effects sponsored SSRIs statins suicide told treated treatment Vioxx voriconazole whistle-blower withdrawal York